BioStock: Cereno Scientific builds high-profile network in CVD

Cereno Scientific has become an emerging leader in epigenetic modulation within CardioVascular Diseases (CVD). This has been possible largely thanks to a close collaboration with the company’s scientific advisors, who are part of a vast network of high-profile experts within the CVD space, including the co-founders of the annual CVCT Forum. BioStock got in touch with Cereno Scientific’s CMO Björn Dahlöf to learn more about the value of such connections.

Read the full interview with Björn Dahlöf at biostock.se:

https://www.biostock.se/en/cereno-scientific-builds-high-profile-network-in-cvd/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se